US Stock MarketDetailed Quotes

VIGL Vigil Neuroscience

Watchlist
  • 2.260
  • -0.070-3.00%
Close Dec 4 16:00 ET
  • 2.260
  • 0.0000.00%
Post 16:00 ET
92.39MMarket Cap-1091P/E (TTM)

About Vigil Neuroscience Company

Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.

Company Profile

SymbolVIGL
Company NameVigil Neuroscience
Listing DateJan 7, 2022
Issue Price14.00
Founded2020
CEODr. Ivana Magovcevic-Liebisch, J.D.,PhD
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address100 Forge Road,Suite 700
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-857-254-4445
Websitehttp://www.vigilneuro.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ivana Magovcevic-Liebisch, J.D.,PhD
  • President, Chief Executive Officer and Director
  • 3.85M
  • Jennifer Ziolkowski, C.P.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 1.70M
  • Petra Kaufmann, F.A.A.N.,M.D.
  • Chief Medical Officer
  • --
  • David L.F. Gray, PhD
  • Chief Science Officer
  • 2.77M
  • Dr. Bruce Booth, D.Phil.
  • Chairman of the Board
  • 165.00K
  • Dr. Suzanne L. Bruhn, PhD
  • Independent Director
  • 138.50K
  • Dr. Gerhard Koenig, PhD
  • Independent Director
  • 136.33K
  • Mary T. Thistle
  • Independent Director
  • 143.83K
  • Stefan Vitorovic, M.B.A.,M.S.
  • Independent Director
  • 136.83K
  • Dr. Samantha L. Budd Haeberlein, PhD
  • Independent Director
  • 311.35K
  • Dr. Cheryl Renee Blanchard, M.S.,PhD
  • Independent Director
  • 140.00K
  • Christopher Verni, J.D.
  • General Counsel and Corporate Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data